Clinical Trials Sponsored by Fund for Cancer Research

Total 4011 results

National Research Center for Hematology, Russia
Enrollme.ru, LLC; Foundation for Cancer Research Support (RakFond)

Completed

Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)

Coronavirus Infection and Hematologic Diseases

Russian Federation
The Danish Research Centre for Chemical Sensitivities
Aage Bangs Fond

Completed

Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity

Multiple Chemical Sensitivity

Denmark
University of Oslo
Oslo University Hospital; The Norwegian Research Fund for General Practice

Recruiting

A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries (PAC-plan)

Pain, Postoperative | Opioid Use | Injury Traumatic

Norway
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research (GFID)

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
Kenya Medical Research Institute
Foundation for Innovative New Diagnostics (FIND)

Unknown

Commercial Typhoid Tests Validation

Typhoid Fever

Kenya
Sheffield Teaching Hospitals NHS Foundation Trust
World Cancer Research Fund International

Terminated

Folate and Protection Against Cervical Cancer

Cervical Cancer

United Kingdom
Agency for Healthcare Research and Quality (AHRQ)
The Commonwealth Fund; California HealthCare Foundation

Completed

Improving Diabetes Efforts Across Language and Literacy (IDEALL)

Diabetes

United States
Universitaire Ziekenhuizen KU Leuven
Vrije Universiteit Brussel; Fund for Scientific Research, Flanders, Belgium

Recruiting

A Computerized, Adaptive Therapeutic Gaming Approach Training Visual Perceptual Skills in Children With CVI (iVision2_WP3)

Cerebral Visual Impairment

Belgium
Weill Medical College of Cornell University
The Edward Grayson Fund for Retinal Research

Unknown

Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases

Subretinal Hemorrhage and Exudative Maculopathy

United States
University Hospital, Ghent
H. Lundbeck A/S; Fund for Scientific Research, Flanders, Belgium

Completed

Functional Neuroimaging in Depression

Major Depression

Belgium
University of Miami
Jay L. Friedland MD Prostate Cancer Research Fund

Recruiting

Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer (HEAT)

Prostate Cancer

United States, Australia, Italy
Weill Medical College of Cornell University
Cancer Research & Treatment Fund, Inc

Terminated

Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer

Prostate Cancer

United States
Andrew E. Place, MD
University of Colorado, Denver; AbbVie; Boston Children's Hospital; Gateway for... and other collaborators

Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Acute Lymphoblastic Leukemia, in Relapse | Therapy-Related Myelodysplastic Syndrome | Acute Leukemia of Ambiguous Lineage | Acute Leukemia of Ambiguous Lineage in Relapse | Myelodysplastic Syndromes, Previously Treated | Acute Lymphoblastic Leukemia With Failed Remission | Myelodysplastic Syndromes... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Gateway for Cancer Research

Active, not recruiting

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Gateway for Cancer Research

Active, not recruiting

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Epithelial Ovarian

United States
European Organisation for Research and Treatment...
Institute of Cancer Research, United Kingdom; Arbeitsgruppe Lebermetastasen...

Terminated

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

Netherlands, United Kingdom, Belgium, France, Germany, Sweden, Hungary, Austria, Egypt, Italy
Jonsson Comprehensive Cancer Center
National Center for Research Resources (NCRR)

Active, not recruiting

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Mental Disorders | Nervous System Diseases | Dyssomnias | Sleep Initiation and Maintenance Disorders | Sleep Disorders

United States
National Research Center for Hematology, Russia
National Research Center for Hematology

Recruiting

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Diffuse Large B-Cell Lymphoma

Russian Federation
Ludwig Institute for Cancer Research
Cancer Research Institute, NY, USA

Terminated

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Unresectable or Metastatic Melanoma

United States, Australia
German Cancer Research Center
National Center for Tumor Diseases, Heidelberg

Recruiting

A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening (MERLIN)

Cancer-related Fatigue

Germany
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center
National Center for Research Resources (NCRR)

Unknown

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

Advanced Cancers

United States
Swiss Group for Clinical Cancer Research

Not yet recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Triple-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Recruiting

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma (SAKK 38/23)

Non-hodgkin Lymphoma, B Cell

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Leukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Prostate Cancer | Prostate Cancer Metastatic

France, Switzerland, Spain, Italy
Swiss Group for Clinical Cancer Research

Completed

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Lung Cancer

Germany, Serbia, Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NSCLC Stage IV | NSCLC Stage IIIB

Switzerland
Duke University
Gateway for Cancer Research

Active, not recruiting

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Breast Cancer

United States
Swiss Group for Clinical Cancer Research

Active, not recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Small Cell Lung Cancer | Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. (SAKK 06/17)

Urothelial Cancer

Germany, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)

Squamous-cell Non-small Cell Lung Cancer

Switzerland
Ludwig Institute for Cancer Research
Medarex

Terminated

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Synovial Sarcoma

United States
Swiss Group for Clinical Cancer Research

Terminated

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Adenocarcinoma | Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Lung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (OptiPOM)

Refractory Multiple Myeloma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Biological Therapy in Treating Patients With Bladder Cancer

Bladder Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

France, Switzerland, Germany, Finland
Swiss Group for Clinical Cancer Research

Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Liver Cancer

Switzerland, Austria, Hungary
Swiss Group for Clinical Cancer Research

Completed

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

Switzerland, Germany
Swiss Group for Clinical Cancer Research

Completed

Metronomic Therapy in Metastatic Breast Cancer.

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

Lymphoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

Switzerland, Netherlands
Swiss Group for Clinical Cancer Research

Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Lymphoma

Switzerland, Italy
Swiss Group for Clinical Cancer Research

Withdrawn

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Prostate Cancer

Switzerland

Clinical Trials Sponsored by Fund for Cancer Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations